AJANTPHARM - Ajanta Pharma Limited
Ajanta Pharma Limited Share Market Related News
-: Stock News :- AJANTPHARM 18-06-2022 To 18-06-2022
✔️ 3 upcoming bonus stocks to watch next week
-: Stock News :- AJANTPHARM 12-05-2022 To 12-05-2022
✔️ Broker's call: Ajanta Pharma (Buy)
✔️ Buy Ajanta Pharma; target of Rs 2080: Motilal Oswal
-: Stock News :- AJANTPHARM 11-05-2022 To 10-05-2022
✔️ Yes Securities sees 42% upside in pharma stock that just announced bonus shares
✔️ Bonus issue fails to lift Ajanta Pharma; stock hits 52-week low on weak Q4
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
✔️ Ajanta Pharma Q4 net profit falls 5% to Rs 151 crore
✔️ Ajanta Pharma Q4 PAT falls 5% to Rs 151 cr; revenue rises to Rs 870 cr
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 07-05-2022 To 10-05-2022
✔️ Pharma stock to consider bonus shares issue next week. Details inside
✔️ Bonus issue fails to lift Ajanta Pharma; stock hits 52-week low on weak Q4
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
✔️ Ajanta Pharma Q4 net profit falls 5% to Rs 151 crore
✔️ Ajanta Pharma Q4 PAT falls 5% to Rs 151 cr; revenue rises to Rs 870 cr
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 06-05-2022 To 10-05-2022
✔️ Pharma stock to consider bonus shares issue next week. Details inside
✔️ Bonus issue fails to lift Ajanta Pharma; stock hits 52-week low on weak Q4
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
✔️ Ajanta Pharma Q4 net profit falls 5% to Rs 151 crore
✔️ Ajanta Pharma Q4 PAT falls 5% to Rs 151 cr; revenue rises to Rs 870 cr
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 02-05-2022 To 10-05-2022
✔️ Market movers: Why Ajanta Pharma & Meghmani Organics surged up to 12%
✔️ Ajanta Pharma to consider bonus share issue, board meet next week
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
✔️ Ajanta Pharma Q4 net profit falls 5% to Rs 151 crore
✔️ Ajanta Pharma Q4 PAT falls 5% to Rs 151 cr; revenue rises to Rs 870 cr
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 16-04-2022 To 10-05-2022
✔️ Why you should buy Ajanta Pharma shares
✔️ Ajanta Pharma to consider bonus share issue, board meet next week
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
✔️ Ajanta Pharma Q4 net profit falls 5% to Rs 151 crore
✔️ Ajanta Pharma Q4 PAT falls 5% to Rs 151 cr; revenue rises to Rs 870 cr
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 24-03-2022 To 10-05-2022
✔️ Broker's call: Ajanta Pharma (Buy)
✔️ Ajanta Pharma to consider bonus share issue, board meet next week
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
✔️ Ajanta Pharma Q4 net profit falls 5% to Rs 151 crore
✔️ Ajanta Pharma Q4 PAT falls 5% to Rs 151 cr; revenue rises to Rs 870 cr
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 10-03-2022 To 10-05-2022
✔️ Buy Ajanta Pharma; target of Rs 2400: Ajcon Global
✔️ Ajanta Pharma to consider bonus share issue, board meet next week
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
✔️ Ajanta Pharma Q4 net profit falls 5% to Rs 151 crore
✔️ Ajanta Pharma Q4 PAT falls 5% to Rs 151 cr; revenue rises to Rs 870 cr
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 03-02-2022 To 10-05-2022
✔️ Buy Ajanta Pharmaceuticals; target of Rs 2605: ICICI Direct
✔️ Ajanta Pharma to consider bonus share issue, board meet next week
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
✔️ Ajanta Pharma Q4 net profit falls 5% to Rs 151 crore
✔️ Ajanta Pharma Q4 PAT falls 5% to Rs 151 cr; revenue rises to Rs 870 cr
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 31-01-2022 To 10-05-2022
✔️ Ajanta Pharma Consolidated December 2021 Net Sales at Rs 837.91 crore, up 11.91% Y-o-Y
✔️ Ajanta Pharma Q3 net up 9% at Rs 192 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
✔️ Ajanta Pharma Q4 net profit falls 5% to Rs 151 crore
✔️ Ajanta Pharma Q4 PAT falls 5% to Rs 151 cr; revenue rises to Rs 870 cr
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 28-12-2021 To 10-05-2022
✔️ Ajanta Pharma board approves up to Rs 286-crore share buyback plan
✔️ Ajanta Pharma board approves up to Rs 286-crore share buyback plan
✔️ Ajanta Pharma gains 5% as board approves share buyback worth Rs 285 crore
✔️ Ajanta Pharma shares surge as board approves share buyback, fixes record date
✔️ Ajanta Pharma Q4 PAT falls 5% to Rs 151 cr; revenue rises to Rs 870 cr
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 24-12-2021 To 10-05-2022
✔️ Buzzing Stocks: Data Patterns, Ajanta Pharma, PSP Projects and other stocks in news today
✔️ Ajanta Pharma to consider a proposal for share buyback
✔️ Ajanta Pharma gains 5% as board approves share buyback worth Rs 285 crore
✔️ Ajanta Pharma shares surge as board approves share buyback, fixes record date
✔️ Ajanta Pharma Q4 PAT falls 5% to Rs 151 cr; revenue rises to Rs 870 cr
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 29-10-2021 To 10-05-2022
✔️ Ajanta Pharma second quarter profit rises 15% to Rs 196 crore
✔️ Ajanta Pharma Q2 profit rises 15% to 196 cr; board approves interim dividend
✔️ Ajanta Pharma gains 5% as board approves share buyback worth Rs 285 crore
✔️ Ajanta Pharma shares surge as board approves share buyback, fixes record date
✔️ Ajanta Pharma Q4 PAT falls 5% to Rs 151 cr; revenue rises to Rs 870 cr
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 02-08-2021 To 10-05-2022
✔️ Buy Ajanta Pharma; target of Rs 2780: Motilal Oswal
✔️ Ajanta Pharma Q2 profit rises 15% to 196 cr; board approves interim dividend
✔️ Ajanta Pharma gains 5% as board approves share buyback worth Rs 285 crore
✔️ Ajanta Pharma shares surge as board approves share buyback, fixes record date
✔️ Ajanta Pharma Q4 PAT falls 5% to Rs 151 cr; revenue rises to Rs 870 cr
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 30-07-2021 To 10-05-2022
✔️ Ajanta Pharma Consolidated June 2021 Net Sales at Rs 747.99 crore, up 11.94% Y-o-Y
✔️ Ajanta Pharma Standalone June 2021 Net Sales at Rs 742.72 crore, up 32.43% Y-o-Y
✔️ Ajanta Pharma gains 5% as board approves share buyback worth Rs 285 crore
✔️ Ajanta Pharma shares surge as board approves share buyback, fixes record date
✔️ Ajanta Pharma Q4 PAT falls 5% to Rs 151 cr; revenue rises to Rs 870 cr
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 25-05-2021 To 10-05-2022
✔️ Buy Ajanta Pharmaceuticals; target of Rs 2250: ICICI Direct
✔️ Ajanta Pharma Standalone June 2021 Net Sales at Rs 742.72 crore, up 32.43% Y-o-Y
✔️ Ajanta Pharma gains 5% as board approves share buyback worth Rs 285 crore
✔️ Ajanta Pharma shares surge as board approves share buyback, fixes record date
✔️ Ajanta Pharma Q4 PAT falls 5% to Rs 151 cr; revenue rises to Rs 870 cr
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 24-05-2021 To 10-05-2022
✔️ Buy Ajanta Pharma; target of Rs 2205: Dolat Capital Market
✔️ Ajanta Pharma Standalone June 2021 Net Sales at Rs 742.72 crore, up 32.43% Y-o-Y
✔️ Ajanta Pharma gains 5% as board approves share buyback worth Rs 285 crore
✔️ Ajanta Pharma shares surge as board approves share buyback, fixes record date
✔️ Ajanta Pharma Q4 PAT falls 5% to Rs 151 cr; revenue rises to Rs 870 cr
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 06-05-2021 To 10-05-2022
✔️ Ajanta Pharma (1,947.8): Buy
✔️ Ajanta Pharma Standalone June 2021 Net Sales at Rs 742.72 crore, up 32.43% Y-o-Y
✔️ Ajanta Pharma gains 5% as board approves share buyback worth Rs 285 crore
✔️ Ajanta Pharma shares surge as board approves share buyback, fixes record date
✔️ Ajanta Pharma Q4 PAT falls 5% to Rs 151 cr; revenue rises to Rs 870 cr
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 01-05-2021 To 10-05-2022
✔️ Ajanta Pharma Q4 net profit up 23 percent at Rs 159 crores
✔️ Ajanta Pharma Q4 net profit up 23 per cent at 159 cr
✔️ Ajanta Pharma gains 5% as board approves share buyback worth Rs 285 crore
✔️ Ajanta Pharma shares surge as board approves share buyback, fixes record date
✔️ Ajanta Pharma Q4 PAT falls 5% to Rs 151 cr; revenue rises to Rs 870 cr
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 12-02-2021 To 10-05-2022
✔️ Buy Ajanta Pharma; target of Rs 2030: Motilal Oswal
✔️ Ajanta Pharma Q4 net profit up 23 per cent at 159 cr
✔️ Ajanta Pharma gains 5% as board approves share buyback worth Rs 285 crore
✔️ Ajanta Pharma shares surge as board approves share buyback, fixes record date
✔️ Ajanta Pharma Q4 PAT falls 5% to Rs 151 cr; revenue rises to Rs 870 cr
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 09-02-2021 To 10-05-2022
✔️ Buy Ajanta Pharma; target of Rs 2208: Dolat Capital Market
✔️ Ajanta Pharma Q4 net profit up 23 per cent at 159 cr
✔️ Ajanta Pharma gains 5% as board approves share buyback worth Rs 285 crore
✔️ Ajanta Pharma shares surge as board approves share buyback, fixes record date
✔️ Ajanta Pharma Q4 PAT falls 5% to Rs 151 cr; revenue rises to Rs 870 cr
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 03-02-2021 To 10-05-2022
✔️ Ajanta Pharma zooms 8% to fresh 52-week high on strong Q3 results
✔️ Ajanta Pharma share price jumps 7%, hits 52-week high as Q3 PAT zooms 64%
✔️ Ajanta Pharma Q3 net profit up 64% to Rs 177 crore
✔️ Ajanta Pharma Q3 net profit up 64 per cent to 177 cr
✔️ Ajanta Pharma Consolidated December 2020 Net Sales at Rs 748.74 crore, up 14.98% Y-o-Y
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 09-11-2020 To 10-05-2022
✔️ Buy Ajanta Pharma; target of Rs 1980: Anand Rathi
✔️ Ajanta Pharma share price jumps 7%, hits 52-week high as Q3 PAT zooms 64%
✔️ Ajanta Pharma Q3 net profit up 64% to Rs 177 crore
✔️ Ajanta Pharma Q3 net profit up 64 per cent to 177 cr
✔️ Ajanta Pharma Consolidated December 2020 Net Sales at Rs 748.74 crore, up 14.98% Y-o-Y
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 07-11-2020 To 10-05-2022
✔️ Accumulate Ajanta Pharma; target of Rs 1771: Dolat Capital Market
✔️ Buy Ajanta Pharmaceuticals; target of Rs 1960: ICICI Direct
✔️ Ajanta Pharma Q3 net profit up 64% to Rs 177 crore
✔️ Ajanta Pharma Q3 net profit up 64 per cent to 177 cr
✔️ Ajanta Pharma Consolidated December 2020 Net Sales at Rs 748.74 crore, up 14.98% Y-o-Y
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 03-11-2020 To 10-05-2022
✔️ Ajanta Pharma board okays buyback
✔️ Buy Ajanta Pharmaceuticals; target of Rs 1960: ICICI Direct
✔️ Ajanta Pharma Q3 net profit up 64% to Rs 177 crore
✔️ Ajanta Pharma Q3 net profit up 64 per cent to 177 cr
✔️ Ajanta Pharma Consolidated December 2020 Net Sales at Rs 748.74 crore, up 14.98% Y-o-Y
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 29-10-2020 To 10-05-2022
✔️ Ajanta Pharma trades firm in a subdued market as board mulls share buyback
✔️ Ajanta Pharma shares gain 4% on share buyback plans
✔️ Ajanta Pharma to meet for buyback
✔️ Ajanta Pharma Q3 net profit up 64 per cent to 177 cr
✔️ Ajanta Pharma Consolidated December 2020 Net Sales at Rs 748.74 crore, up 14.98% Y-o-Y
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 03-08-2020 To 10-05-2022
✔️ Buy Ajanta Pharmaceuticals; target of Rs 1810: ICICI Direct
✔️ Ajanta Pharma shares gain 4% on share buyback plans
✔️ Ajanta Pharma to meet for buyback
✔️ Ajanta Pharma Q3 net profit up 64 per cent to 177 cr
✔️ Ajanta Pharma Consolidated December 2020 Net Sales at Rs 748.74 crore, up 14.98% Y-o-Y
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 31-07-2020 To 10-05-2022
✔️ Ajanta Pharma Standalone June 2020 Net Sales at Rs 560.85 crore, up 2.77% Y-o-Y
✔️ Ajanta Pharma Q1 profit up 29% at Rs 148 crore
✔️ Ajanta Pharma Q1 profit up 29% at 148 crore
✔️ Ajanta Pharma Q3 net profit up 64 per cent to 177 cr
✔️ Ajanta Pharma Consolidated December 2020 Net Sales at Rs 748.74 crore, up 14.98% Y-o-Y
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 18-07-2020 To 10-05-2022
✔️ Pharma stocks in focus! Lupin, Ajanta Pharma are on next leg of upside: Umesh Mehta
✔️ Ajanta Pharma Q1 profit up 29% at Rs 148 crore
✔️ Ajanta Pharma Q1 profit up 29% at 148 crore
✔️ Ajanta Pharma Q3 net profit up 64 per cent to 177 cr
✔️ Ajanta Pharma Consolidated December 2020 Net Sales at Rs 748.74 crore, up 14.98% Y-o-Y
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 25-05-2020 To 10-05-2022
✔️ Buy Ajanta Pharmaceuticals; target of Rs 1730: ICICI Direct
✔️ Ajanta Pharma Q1 profit up 29% at Rs 148 crore
✔️ Ajanta Pharma Q1 profit up 29% at 148 crore
✔️ Ajanta Pharma Q3 net profit up 64 per cent to 177 cr
✔️ Ajanta Pharma Consolidated December 2020 Net Sales at Rs 748.74 crore, up 14.98% Y-o-Y
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 21-05-2020 To 10-05-2022
✔️ Buy Ajanta Pharma; target of Rs 1700: Motilal Oswal
✔️ Ajanta Pharma shares gain 3% as Motilal Oswal stays bullish on stock after Q4 results
✔️ Ajanta Pharma delivers a decent Q4, but growth may be priced in
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 09-04-2020 To 10-05-2022
✔️ Ajanta Pharma share price jumps 8% on US FDA nod for cholesterol drug
✔️ Ajanta Pharma shares gain 3% as Motilal Oswal stays bullish on stock after Q4 results
✔️ Ajanta Pharma delivers a decent Q4, but growth may be priced in
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 24-02-2020 To 10-05-2022
✔️ Buoyed by US revenues, higher growth trajectory awaits Ajanta Pharma
✔️ Ajanta Pharma shares gain 3% as Motilal Oswal stays bullish on stock after Q4 results
✔️ Ajanta Pharma delivers a decent Q4, but growth may be priced in
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 06-02-2020 To 10-05-2022
✔️ Ajanta Pharma surges 11% on strong Q3 performance, profit jumps 61% YoY
✔️ Ajanta Pharma shares gain 3% as Motilal Oswal stays bullish on stock after Q4 results
✔️ Ajanta Pharma delivers a decent Q4, but growth may be priced in
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 05-11-2019 To 10-05-2022
✔️ Ajanta Pharma Q2 net profit dips 7% to Rs 116 crore; stock ends flat
✔️ Ajanta Pharma shares gain 3% as Motilal Oswal stays bullish on stock after Q4 results
✔️ Ajanta Pharma delivers a decent Q4, but growth may be priced in
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 03-09-2019 To 10-05-2022
✔️ Domestic business driving Ajanta Pharma's growth prospects
✔️ Ajanta Pharma shares gain 3% as Motilal Oswal stays bullish on stock after Q4 results
✔️ Ajanta Pharma delivers a decent Q4, but growth may be priced in
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 02-08-2019 To 10-05-2022
✔️ Ajanta Pharma (957.3): Buy
✔️ Ajanta Pharma shares gain 3% as Motilal Oswal stays bullish on stock after Q4 results
✔️ Ajanta Pharma delivers a decent Q4, but growth may be priced in
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 01-08-2019 To 10-05-2022
✔️ Ajanta Pharma rises on Q1 profit
✔️ Ajanta Pharma shares gain 3% as Motilal Oswal stays bullish on stock after Q4 results
✔️ Ajanta Pharma delivers a decent Q4, but growth may be priced in
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 30-04-2019 To 10-05-2022
✔️ Ajanta Pharma Q4 consolidated net drops 6% to Rs 89 cr
✔️ Ajanta Pharma shares gain 3% as Motilal Oswal stays bullish on stock after Q4 results
✔️ Ajanta Pharma delivers a decent Q4, but growth may be priced in
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 31-01-2019 To 10-05-2022
✔️ Share buyback nod fails to lift Ajanta Pharma; falls 7% on weak Q3 results
✔️ Ajanta Pharma shares gain 3% as Motilal Oswal stays bullish on stock after Q4 results
✔️ Ajanta Pharma delivers a decent Q4, but growth may be priced in
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 30-01-2019 To 10-05-2022
✔️ Ajanta Pharma board okays buyback at 1,300 a share
✔️ Ajanta Pharma shares gain 3% as Motilal Oswal stays bullish on stock after Q4 results
✔️ Ajanta Pharma delivers a decent Q4, but growth may be priced in
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 06-01-2019 To 10-05-2022
✔️ Ajanta Pharma: Relief in sight
✔️ Ajanta Pharma shares gain 3% as Motilal Oswal stays bullish on stock after Q4 results
✔️ Ajanta Pharma delivers a decent Q4, but growth may be priced in
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 05-01-2019 To 10-05-2022
✔️ Ajanta Pharma: Relief in sight
✔️ Ajanta Pharma shares gain 3% as Motilal Oswal stays bullish on stock after Q4 results
✔️ Ajanta Pharma delivers a decent Q4, but growth may be priced in
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 03-12-2018 To 10-05-2022
✔️ Top buy, sell, hold ideas from D-St experts
✔️ Ajanta Pharma shares gain 3% as Motilal Oswal stays bullish on stock after Q4 results
✔️ Ajanta Pharma delivers a decent Q4, but growth may be priced in
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 31-10-2018 To 10-05-2022
✔️ Ajanta Pharma Q2 profit dips 5% to 125 cr
✔️ Ajanta Pharma shares gain 3% as Motilal Oswal stays bullish on stock after Q4 results
✔️ Ajanta Pharma delivers a decent Q4, but growth may be priced in
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 08-10-2018 To 10-05-2022
✔️ Broker's Call: Ajanta Pharma (Buy)
✔️ Ajanta Pharma shares gain 3% as Motilal Oswal stays bullish on stock after Q4 results
✔️ Ajanta Pharma delivers a decent Q4, but growth may be priced in
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 02-08-2018 To 10-05-2022
✔️ Ajanta Pharma plans big US push
✔️ Ajanta Pharma shares gain 3% as Motilal Oswal stays bullish on stock after Q4 results
✔️ Ajanta Pharma delivers a decent Q4, but growth may be priced in
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 27-07-2018 To 10-05-2022
✔️ USFDA completes Ajanta Pharma Dahej facility audit
✔️ Ajanta Pharma shares gain 3% as Motilal Oswal stays bullish on stock after Q4 results
✔️ Ajanta Pharma delivers a decent Q4, but growth may be priced in
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 16-07-2018 To 10-05-2022
✔️ Ajanta Pharma under scanner for marketing unapproved drugs
✔️ Ajanta Pharma shares gain 3% as Motilal Oswal stays bullish on stock after Q4 results
✔️ Ajanta Pharma delivers a decent Q4, but growth may be priced in
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 08-07-2018 To 10-05-2022
✔️ Ajanta Pharma still in a downtrend
✔️ Ajanta Pharma shares gain 3% as Motilal Oswal stays bullish on stock after Q4 results
✔️ Ajanta Pharma delivers a decent Q4, but growth may be priced in
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 01-06-2018 To 10-05-2022
✔️ Ajanta Pharma: Reduction in Africa biz may offset branded generic sales
✔️ Ajanta Pharma shares gain 3% as Motilal Oswal stays bullish on stock after Q4 results
✔️ Ajanta Pharma delivers a decent Q4, but growth may be priced in
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 02-05-2018 To 10-05-2022
✔️ Ajanta Pharma Q4 profit down 17% at Rs94 crore
✔️ Ajanta Pharma shares gain 3% as Motilal Oswal stays bullish on stock after Q4 results
✔️ Ajanta Pharma delivers a decent Q4, but growth may be priced in
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 14-03-2018 To 10-05-2022
✔️ Broker's Call: Ajanta Pharma (Buy)
✔️ Ajanta Pharma shares gain 3% as Motilal Oswal stays bullish on stock after Q4 results
✔️ Ajanta Pharma delivers a decent Q4, but growth may be priced in
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 23-02-2018 To 10-05-2022
✔️ Broker's call: Ajanta Pharma (Hold)
✔️ Ajanta Pharma shares gain 3% as Motilal Oswal stays bullish on stock after Q4 results
✔️ Ajanta Pharma delivers a decent Q4, but growth may be priced in
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 13-12-2017 To 10-05-2022
✔️ Ajanta Pharma: Growth driven by India, US markets
✔️ Ajanta Pharma shares gain 3% as Motilal Oswal stays bullish on stock after Q4 results
✔️ Ajanta Pharma delivers a decent Q4, but growth may be priced in
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 31-10-2017 To 10-05-2022
✔️ Ajanta Pharma Q2 net profit up marginally to Rs132 crore
✔️ Ajanta Pharma posts marginal rise in net profit
✔️ Ajanta Pharma Q2 net up marginally at Rs 132 cr
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 04-09-2017 To 10-05-2022
✔️ Ajanta Pharma gets USFDA nod for Entacapone tablets
✔️ Ajanta Pharma gets USFDA nod for Parkinson's disease tablet
✔️ Ajanta Pharma Q2 net up marginally at Rs 132 cr
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 31-08-2017 To 10-05-2022
✔️ Ajanta Pharma launches pain relief tablets in US market
✔️ Ajanta Pharma Launches Pain Relief Tablets In US
✔️ Ajanta Pharma Q2 net up marginally at Rs 132 cr
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 09-08-2017 To 10-05-2022
✔️ Ajanta Pharma net declines by 21% to Rs. 95 cr in Q1
✔️ Ajanta Pharma Launches Pain Relief Tablets In US
✔️ Ajanta Pharma Q2 net up marginally at Rs 132 cr
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 11-07-2017 To 10-05-2022
✔️ Promoter firm reduces stake in Ajanta Pharma
✔️ Ajanta Pharma Launches Pain Relief Tablets In US
✔️ Ajanta Pharma Q2 net up marginally at Rs 132 cr
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 03-05-2017 To 10-05-2022
✔️ Ajanta Pharma Q4 net profit rises 4.64% to Rs 114 crore
✔️ Ajanta Pharma Launches Pain Relief Tablets In US
✔️ Ajanta Pharma Q2 net up marginally at Rs 132 cr
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 10-04-2017 To 10-05-2022
✔️ US go-ahead to lift Ajanta Pharma
✔️ USFDA completes Ajanta Pharma Dahej unit
✔️ Ajanta Pharma Q2 net up marginally at Rs 132 cr
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 09-02-2017 To 10-05-2022
✔️ Ajanta Pharma Gets USFDA Observation For Paithan Facility
✔️ Ajanta Pharma gets USFDA observation for Paithan facility
✔️ Ajanta Pharma Q2 net up marginally at Rs 132 cr
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 24-01-2017 To 10-05-2022
✔️ Ajanta Pharma disputes ET article on FDA import alert
✔️ Ajanta Pharma Denies Alert From USFDA, Shares Fall
✔️ Ajanta Pharma pares early losses post clarification on USFDA import alert
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 09-01-2017 To 10-05-2022
✔️ Ajanta Pharma: USFDA nod adds strength
✔️ Ajanta Pharma Denies Alert From USFDA, Shares Fall
✔️ Ajanta Pharma pares early losses post clarification on USFDA import alert
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 02-11-2016 To 10-05-2022
✔️ Ajanta Pharma launches BP lowering tablets in US
✔️ Ajanta Pharma Denies Alert From USFDA, Shares Fall
✔️ Ajanta Pharma pares early losses post clarification on USFDA import alert
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 26-10-2016 To 10-05-2022
✔️ Ajanta Pharma Q2 net up 26% at Rs 130.66 crore
✔️ Ajanta Pharma Denies Alert From USFDA, Shares Fall
✔️ Ajanta Pharma pares early losses post clarification on USFDA import alert
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 07-10-2016 To 10-05-2022
✔️ Chart Check: Reliance Industries, Arvind, Ajanta Pharma, Bank of India
✔️ Ajanta Pharma Denies Alert From USFDA, Shares Fall
✔️ Ajanta Pharma pares early losses post clarification on USFDA import alert
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 02-09-2016 To 10-05-2022
✔️ Buy Ajanta Pharma Ltd., target Rs 2344.0 : Anand Rathi
✔️ Ajanta Pharma Denies Alert From USFDA, Shares Fall
✔️ Ajanta Pharma pares early losses post clarification on USFDA import alert
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 19-08-2016 To 10-05-2022
✔️ Buy Ajanta Pharma Ltd., target Rs 2025.0 : Dr CK Narayan
✔️ Ajanta Pharma Denies Alert From USFDA, Shares Fall
✔️ Ajanta Pharma pares early losses post clarification on USFDA import alert
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 12-08-2016 To 10-05-2022
✔️ Buy Ajanta Pharma Ltd., target Rs 1950.0 : IIFL
✔️ Ajanta Pharma Denies Alert From USFDA, Shares Fall
✔️ Ajanta Pharma pares early losses post clarification on USFDA import alert
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 29-07-2016 To 10-05-2022
✔️ Ajanta Pharma gets USFDA nod to launch heartburn combination drug
✔️ Ajanta Pharma gets USFDA nod for generic acid reflux drug
✔️ Ajanta Pharma gets USFDA nod for generic acid reflux drug
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 26-07-2016 To 10-05-2022
✔️ Ajanta Pharma Q1 net up 39 per cent at Rs 119.55 crore
✔️ Ajanta Pharma gets USFDA nod for generic acid reflux drug
✔️ Ajanta Pharma gets USFDA nod for generic acid reflux drug
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 18-07-2016 To 10-05-2022
✔️ Ajanta Pharma launches acid reflux drug in US
✔️ Ajanta Pharma launches acid reflux drug in US
✔️ Ajanta Pharma launches acid reflux drug in US
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 11-07-2016 To 10-05-2022
✔️ Buy Ajanta Pharma Ltd., target Rs 1665: Dr CK Narayan
✔️ Ajanta Pharma launches acid reflux drug in US
✔️ Ajanta Pharma launches acid reflux drug in US
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 22-06-2016 To 10-05-2022
✔️ Sell Ajanta Pharma, target Rs 1410: Mitesh Thacker
✔️ Ajanta Pharma launches acid reflux drug in US
✔️ Ajanta Pharma launches acid reflux drug in US
✔️ Ajanta Pharma Consolidated March 2020 Net Sales at Rs 681.96 crore, up 32.38% Y-o-Y
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 14-06-2016 To 10-05-2022
✔️ Ajanta Pharma launches anti-dementia drug in US
✔️ Ajanta Pharma surges 2% on USFDA nod
✔️ Ajanta Pharma launches anti-dementia drug in US
✔️ Ajanta Pharma launches anti-dementia drug in US
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 24-05-2016 To 10-05-2022
✔️ Ajanta Pharma gets USFDA nod for migraine pain relief drug
✔️ Ajanta Pharma receives US FDA approval for migraine drug
✔️ Ajanta Pharma gets USFDA nod for migraine pain relief drug
✔️ Ajanta Pharma launches anti-dementia drug in US
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 08-05-2016 To 10-05-2022
✔️ Ajanta Pharma plans to invest over Rs 100 crore to expand Wok Express
✔️ Ajanta Pharma plans to invest over Rs 100 crore to expand Wok Express
✔️ Ajanta Pharma gets USFDA nod for migraine pain relief drug
✔️ Ajanta Pharma launches anti-dementia drug in US
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 06-05-2016 To 10-05-2022
✔️ Buy Ajanta Pharma with a target of Rs 1,560: Dr CK Narayan
✔️ Ajanta Pharma plans to invest over Rs 100 crore to expand Wok Express
✔️ Ajanta Pharma gets USFDA nod for migraine pain relief drug
✔️ Ajanta Pharma launches anti-dementia drug in US
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 29-04-2016 To 10-05-2022
✔️ Ajanta Pharma's Q4 profit jumps 43% to Rs106 crore
✔️ Ajanta Pharma Q4 net up 43% at Rs 106 cr
✔️ Ajanta Pharma gets USFDA nod for migraine pain relief drug
✔️ Ajanta Pharma launches anti-dementia drug in US
✔️ Ajanta Pharma Q4 net profit up 45% to Rs 129 crore
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 07-03-2016 To 10-05-2022
✔️ Ajanta Pharma Gets USFDA Nod For Migraine Pain Relief Drug
✔️ Ajanta Pharma shares jump nearly 4% on USFDA nod for drug
✔️ Ajanta Pharma gains on USFDA nod for Almotriptan Malate tablets
✔️ Ajanta Pharma gets US FDA nod for migraine pain relief drug
✔️ Ajanta Pharma gets USFDA nod for migraine pain relief drug
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 14-02-2016 To 10-05-2022
✔️ Tata Steel wins TIME's best in class for manufacturing award
✔️ Ajanta Pharma shares jump nearly 4% on USFDA nod for drug
✔️ Ajanta Pharma gains on USFDA nod for Almotriptan Malate tablets
✔️ Ajanta Pharma gets US FDA nod for migraine pain relief drug
✔️ Ajanta Pharma gets USFDA nod for migraine pain relief drug
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 01-02-2016 To 10-05-2022
✔️ Ajanta Pharma Q3 net up 20% at Rs 111 crore
✔️ Ajanta Pharma Q3 net up 20% at Rs 111 cr
✔️ Ajanta Pharma Q3 net up 20 per cent at Rs 111.3 crore
✔️ Ajanta Pharma gets US FDA nod for migraine pain relief drug
✔️ Ajanta Pharma gets USFDA nod for migraine pain relief drug
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 03-12-2015 To 10-05-2022
✔️ Ajanta Pharma launches generic asthma treatment tablets in US
✔️ Ajanta Pharma launches montelukast IR and montelukast chewable tablets
✔️ Ajanta Pharma Q3 net up 20 per cent at Rs 111.3 crore
✔️ Ajanta Pharma gets US FDA nod for migraine pain relief drug
✔️ Ajanta Pharma gets USFDA nod for migraine pain relief drug
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 16-11-2015 To 10-05-2022
✔️ Drug launch in US to aid Ajanta Pharma
✔️ Ajanta Pharma launches montelukast IR and montelukast chewable tablets
✔️ Ajanta Pharma Q3 net up 20 per cent at Rs 111.3 crore
✔️ Ajanta Pharma gets US FDA nod for migraine pain relief drug
✔️ Ajanta Pharma gets USFDA nod for migraine pain relief drug
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 30-10-2015 To 10-05-2022
✔️ Ajanta Pharma Q2 net up 20% at Rs 100 crore
✔️ Ajanta Pharma Q2 net up 20.4%
✔️ Ajanta Pharma posts Rs 438 crore consolidated revenue in Q2 of FY 2015-16
✔️ Ajanta Pharma gets US FDA nod for migraine pain relief drug
✔️ Ajanta Pharma gets USFDA nod for migraine pain relief drug
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 21-09-2015 To 10-05-2022
✔️ Assam govt clears three investment proposals amounting to Rs 464 cr
✔️ Ajanta Pharma Q2 net up 20.4%
✔️ Ajanta Pharma posts Rs 438 crore consolidated revenue in Q2 of FY 2015-16
✔️ Ajanta Pharma gets US FDA nod for migraine pain relief drug
✔️ Ajanta Pharma gets USFDA nod for migraine pain relief drug
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 07-09-2015 To 10-05-2022
✔️ Ajanta Pharma falls 6%; 'technical charts weak'
✔️ Ajanta Pharma Q2 net up 20.4%
✔️ Ajanta Pharma posts Rs 438 crore consolidated revenue in Q2 of FY 2015-16
✔️ Ajanta Pharma gets US FDA nod for migraine pain relief drug
✔️ Ajanta Pharma gets USFDA nod for migraine pain relief drug
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 04-08-2015 To 10-05-2022
✔️ Ajanta Pharma gains on getting approvals for three ANDAs
✔️ Company news
✔️ Ajanta Pharma gets US FDA nod for generic asthma treatment drug
✔️ Ajanta Pharma Gets US Regulator's Nod for Asthma Treatment Drug
✔️ Ajanta Pharma gets USFDA nod for migraine pain relief drug
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 23-06-2022 To 23-06-2022
✔️ Midcap pharma stock falls on record date of bonus shares issue
✔️ Ajanta Pharma extends fall, slips 2%; stock turned ex-bonus on Wednesday
-: Stock News :- AJANTPHARM 18-06-2022 To 23-06-2022
✔️ 3 upcoming bonus stocks to watch next week
✔️ Ajanta Pharma extends fall, slips 2%; stock turned ex-bonus on Wednesday
-: Stock News :- AJANTPHARM 03-11-2022 To 03-11-2022
✔️ Q2FY23 Quarterly Result Announced for Ajanta Pharma Ltd.
-: Stock News :- AJANTPHARM 07-11-2022 To 07-11-2022
✔️ Buy Ajanta Pharmaceuticals; target of Rs 1505: ICICI Direct
-: Stock News :- AJANTPHARM 28-07-2022 To 28-07-2022
✔️ Q1FY23 Quarterly Result Announced for Ajanta Pharma Ltd.
-: Stock News :- AJANTPHARM 10-05-2022 To 10-05-2022
✔️ Earnings Call for Q4FY22 of Ajanta Pharma
✔️ Bonus issue fails to lift Ajanta Pharma; stock hits 52-week low on weak Q4
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
✔️ Ajanta Pharma Q4 net profit falls 5% to Rs 151 crore
✔️ Ajanta Pharma Q4 PAT falls 5% to Rs 151 cr; revenue rises to Rs 870 cr
✔️ Ajanta Pharma to issue bonus shares in the ratio of 1:2
-: Stock News :- AJANTPHARM 21-12-2022 To 21-12-2022
✔️ Promoter entities to sell 4.6% stake in Ajanta Pharma via block deal Thursday
-: Stock News :- AJANTPHARM 03-02-2023 To 03-02-2023
✔️ Buy Ajanta Pharma; target of Rs 1410: Motilal Oswal
✔️ Buy Ajanta Pharma; target of Rs 1400: YES Securities
-: Stock News :- AJANTPHARM 01-02-2023 To 03-02-2023
✔️ Q3FY23 Quarterly Result Announced for Ajanta Pharma Ltd.
✔️ Buy Ajanta Pharma; target of Rs 1400: YES Securities
-: Stock News :- AJANTPHARM 21-12-2022 To 03-02-2023
✔️ Promoter entities to sell 4.6% stake in Ajanta Pharma via block deal Thursday
✔️ Buy Ajanta Pharma; target of Rs 1400: YES Securities
-: Stock News :- AJANTPHARM 07-11-2022 To 03-02-2023
✔️ Buy Ajanta Pharmaceuticals; target of Rs 1505: ICICI Direct
✔️ Buy Ajanta Pharma; target of Rs 1400: YES Securities
-: Stock News :- AJANTPHARM 03-11-2022 To 03-02-2023
✔️ Q2FY23 Quarterly Result Announced for Ajanta Pharma Ltd.
✔️ Buy Ajanta Pharma; target of Rs 1400: YES Securities
-: Stock News :- AJANTPHARM 28-07-2022 To 03-02-2023
✔️ Q1FY23 Quarterly Result Announced for Ajanta Pharma Ltd.
✔️ Buy Ajanta Pharma; target of Rs 1400: YES Securities
-: Stock News :- AJANTPHARM 08-03-2023 To 08-03-2023
✔️ Ajanta Pharma edges higher on news of likely share buyback
-: Stock News :- AJANTPHARM 06-03-2023 To 06-03-2023
✔️ Ajanta Pharma Board to consider buyback of shares on 10 March
-: Stock News :- AJANTPHARM 13-03-2023 To 13-03-2023
✔️ Buy Ajanta Pharma; target of Rs 1410: Motilal Oswal
-: Stock News :- AJANTPHARM 10-03-2023 To 10-03-2023
✔️ Ajanta Pharma share buyback announced. Price, record date, key details to know
No More Records...